Our findings align with a retrospective prognostic analysis of 437 samples from patients with gastric cancer, showing that presence of MUC16 mutations were associated with better prognosis when compared to patients without MUC16 mutations.22 The gene discussed is MUC16; the disease is gastric cancer.